Aehr Test Systems Q3 Fiscal 2026 Earnings Highlights

Written by Emily J. Thompson, Senior Investment Analyst

Source: seekingalpha

Updated: 1 hour ago

0mins

AEHR-3.66%

Should l Buy AEHR?

Source: seekingalpha

Strong Order Growth: Aehr Test Systems reported over $37 million in bookings for Q3 fiscal 2026, with a book-to-bill ratio exceeding 3.5x, indicating robust momentum across multiple market segments that is expected to drive future revenue growth.
Record Effective Backlog: The effective backlog reached a record $50.9 million at the end of Q3, significantly up from $18.7 million in the previous quarter, reflecting sustained market demand and enhancing the company's financial stability.
New Customer Orders: The company secured an initial order from a major silicon photonics customer for multiple high-power FOX-XP wafer-level burn-in systems, scheduled to ship in Q4 fiscal 2026, which will further expand its customer base and market share.
Improved Profitability Outlook: Management expects full-year fiscal 2026 revenue to be on the high side of the $45 million to $50 million range and anticipates returning to non-GAAP profitability in Q4, indicating a positive shift in revenue and profitability prospects.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy AEHR?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on AEHR

Wall Street analysts forecast AEHR stock price to fall

3 Analyst Rating

1 Buy

2 Hold

0 Sell

Moderate Buy

Current: 52.160

Low

21.00

Averages

25.00

High

29.00

Current: 52.160

Low

21.00

Averages

25.00

High

29.00

Lake Street

Buy

upgrade

$29 -> $50

2026-03-05

Reason

Lake Street

Price Target

$29 -> $50

AI Analysis

2026-03-05

upgrade

Buy

Reason

Lake Street raised the firm's price target on Aehr Test Systems to $50 from $29 and keeps a Buy rating on the shares. The firm, which continues to expect a significant revenue ramp in FY27 driven by AI-related orders, has raised its FY27 sales estimates to $80M from $73M to account for recent order announcements and "the positive tone from management" when the firm recently hosted a fireside chat and a series of investor meetings.

William Blair

Market Perform -> Outperform

upgrade

$50 -> $70

2026-03-02

Reason

William Blair

Price Target

$50 -> $70

2026-03-02

upgrade

Market Perform -> Outperform

Reason

William Blair upgraded Aehr Test Systems to Outperform from Market Perform. The firm estimates the stock's fair value between $50 and $70 per share. The analyst believes Aehr has secured multiple design wins for both its package level burn-in and wafer level burn-in across at least two major customers. Blair's proprietary model for burn-in tools for AI processors in 2030 forecasts a $1.5B to $2.3B total addressable market range. It estimates a 30% market share reflects a fair value of $50 to $70 per share for Aehr Test.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for AEHR

Unlock Now

About AEHR

Aehr Test Systems, Inc. offers test solutions for testing, burning-in, and stabilizing semiconductor devices in wafer level, singulated die, and package part form. Its products include the FOX-P family of test and burn-in systems and FOX WaferPak Aligner, FOX WaferPak Contactor, FOX DiePak Carrier and FOX DiePak Loader. The FOX-XP and FOX-NP systems are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in and stabilize a range of devices such as silicon carbide-based and other power semiconductors, 2D and 3D sensors used in phones, tablets and other computing devices. FOX-CP system is a single-wafer compact test solution for logic, memory and photonic devices. FOX WaferPak Contactor contains a full wafer contactor capable of testing wafers up to 300 millimeters that enables integrated circuit manufacturers to perform testing, burn-in and stabilization of full wafers on the FOX-P systems. It offers packaged part reliability/burn-in test solutions.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

AEHR TEST SYSTEMS Q3 ADJUSTED EPS AT USD -0.05, BEATING IBES ESTIMATE OF USD -0.07

8 hours agomoomoo

Q3 Adjusted EPS: The adjusted earnings per share (EPS) for Q3 is reported at USD -0.05.
IBES Estimate: The IBES estimate for EPS is slightly lower at USD -0.07.

AEHR TEST SYSTEMS Q3 ADJUSTED NET INCOME REACHES USD -1.523 MILLION, BEATING IBES ESTIMATE OF USD -2.1 MILLION

8 hours agomoomoo

Q3 Adjusted Net Income: The adjusted net income for Q3 is reported at USD 1.523 million.
Comparison with Estimates: This figure is lower than the estimated net income of USD 2.1 million.

AEHR TEST SYSTEMS Q3 SALES REACH USD 10.313 MILLION, BELOW IBES ESTIMATE OF USD 10.8 MILLION

8 hours agomoomoo

Sales Comparison: A reported sales figure of USD 10.313 million for Q3 contrasts with an estimate of USD 10.8 million.
Performance Analysis: The discrepancy between actual sales and estimates indicates potential challenges in meeting market expectations.

AEHR TEST SYSTEMS REPORTS Q3 NET LOSS OF USD 3.203 MILLION

8 hours agomoomoo

Financial Performance: The company reported a net income of USD 3.203 million for the third quarter.
Earnings Overview: This figure reflects the financial health and operational efficiency of the business during the specified period.

Aehr Test Systems Q3 Earnings Announcement Scheduled

1 day agoseekingalpha

Earnings Release Date: Aehr Test Systems is set to announce its Q3 earnings on April 7th after market close, with a consensus EPS estimate of -$0.07, reflecting a significant 200% year-over-year decline, indicating substantial profitability challenges ahead.
Revenue Decline Forecast: The anticipated revenue for Q3 is $10.85 million, representing a 40.7% year-over-year drop, which highlights potential challenges the company faces in maintaining sales growth amidst competitive pressures.
Historical Performance Review: Over the past two years, Aehr has beaten EPS estimates 63% of the time and revenue estimates 63% of the time, although recent downward revisions in estimates suggest a weakening market confidence in the company's future performance.
Analyst Perspectives: Recent analyst commentary reflects a divergence in views, with expectations for sales growth tempered by a “show-me” narrative, indicating a cautious outlook on the company's future performance that may impact investor sentiment.